Toshiro Kawakita
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications
Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.
Journal: Transplantation and cellular therapy
Published: May 25, 2026
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation.
Journal: Bone marrow transplantation
Published: March 18, 2026
Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.
Journal: Scientific reports
Published: March 16, 2026
Adjusting Disease Risk Index for Regional Variations and Donor Selection.
Journal: Transplantation and cellular therapy
Published: February 20, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: February 05, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 years.
Journal: International journal of hematology
Published: January 17, 2026
A case of primary testicular adult T-cell leukemia/lymphoma (ATLL): ATLL of immune privileged site.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: December 24, 2025
Are matched-related donors always the best choice? A retrospective study exploring the potential of umbilical cord blood.
Journal: International journal of hematology
Published: December 13, 2025
Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.
Journal: British journal of haematology
Published: December 05, 2025
Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma.
Journal: Hematological oncology
Published: October 13, 2025
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experience.
Journal: British journal of haematology
Published: October 08, 2025
Last Updated: 09/26/2026